Samsung Medison Leads Women’s Health with Life Cycle Ultrasound Solutions at ISUOG 2025: Expert View by Spherical Insights

At ISUOG 2025 in Cancún, Mexico, Samsung Medison showcased its upgraded HERA Z20 AI-powered ultrasound system designed for women’s healthcare across all life stages from fertility and pregnancy to menopause. The company introduced advanced features such as PelvicAssist™ for automated pelvic analysis, Live ViewAssist™ for automatic fetal scan measurements, and QualityCheck for image accuracy verification. Samsung also launched the compact Mini ER7 probe to improve patient comfort during gynecological exams. The system aims to improve diagnostic accuracy, reduce scan time, and support high-risk pregnancy monitoring through AI-driven imaging and workflow automation.

 

• The global Diagnostic Imaging Market was valued at approximately USD 48–49 billion in 2025 and is projected to reach nearly USD 74–84 billion by 2035, driven by rising adoption of AI-powered ultrasound, growing chronic disease cases, and increasing demand for early diagnostics and women’s healthcare imaging. 
• Governments and healthcare organizations worldwide are increasing investments in maternal healthcare and diagnostic imaging infrastructure through initiatives focused on prenatal screening, women’s health access, telehealth imaging, and AI-assisted diagnostics. ISUOG and industry collaborations are also supporting global ultrasound education and clinical standardization. 
• Samsung Medison launched the upgraded HERA Z20 AI-powered ultrasound system at ISUOG 2025, introducing technologies such as PelvicAssist™, HeartAssist™, Live ViewAssist™, and QualityCheck to improve fetal diagnostics, gynecological imaging, and high-risk pregnancy monitoring while reducing diagnostic time. 
• The company also invested in patient-centric innovation with the launch of the Mini ER7 probe featuring a head size nearly 63% smaller than conventional probes to improve comfort during gynecological examinations, especially for adolescent and elderly patients. 

 

MEXICO: Samsung Medison is garnering attention from the global medical community with its ultrasound diagnostic solutions across the women’s life stage from fetal stage to menopause.

 

At the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG 2025) in Cancún, Mexico on September 14, Samsung Medison will showcase its comprehensive women’s health solution under the theme “From Challenges to Solutions: Experience the Innovation.”

 

From Fetal Stage to Menopause Ultrasound Solution Demonstration Tailored to Women’s Life Stages

The highlight of upgraded HERA Z20, to be unveiled at ISUOG, features diagnostics tailored to every life stage of women. It supports healthcare professionals in managing women’s health comprehensively with a single equipment, enabling dedicated management of women’s health across all stages, from adolescent gynecological conditions and fertility to maternity and aging.

 

Newly added PelvicAssist™ and three types of reporting features propose diagnostic support innovation for the women and healthcare professionals whom have difficulties due to the gynecological conditions. PelvicAssist™ automatically analyzes multiple pelvic regions and measures the levator hiatus area, providing the 3D image.

 

Due to the complexity of anatomical structures, considerable time is required to precisely assess and report lesion location, size, shape and degree of invasion. In response, Samsung Medison has unveiled tailored diagnostic reporting solution based on standardized clinical guidelines.

 

Fibroid 2D, which simplifies the reporting procedure for uterine fibroid by applying The International Federation of Gynecology and Obstetrics (FIGO) guideline. IDEA and IETA highly enhanced diagnostic workflow efficiency by supporting scan procedures and reporting based on guidelines for endometriosis and endometrial tumor evaluation, respectively.

 

The ultra-compact probe Mini ER7, developed to minimize patient discomfort during gynecological examinations by offering 63% smaller head compared to conventional probes, it is expected to significantly reduce the burden for adolescent and elderly patients.

 

 

Ultrasound Solutions for High-risk Pregnancy Care and Enhanced Clinical Efficiency

With maternal age on the rise, high-risk pregnancies are becoming common. In response to this social challenge, Samsung Medison has integrated Ophthalmic Artery feature to detect systemic vasoconstriction in early stages — a key factor of pre-eclampsia.

 

As the Ophthalmic Artery branches directly from the internal carotid artery, it allows for indirect monitoring of cerebral blood flow, which is difficult to access, enabling the early detection of potential cardiovascular disease. The expanded HeartAssist™ further supports maternal health by real-time monitoring of cardiovascular conditions during pregnancy.

 

Healthcare professional’s work efficiency is at the center of Samsung Medison’s innovation. Live ViewAssist™ automatically extracts up to 39 ultrasound cross-sectional images, provides automated annotations and measurement results for key parameters throughout the pregnancy cycle, and reduce diagnostic time.

 

The integrated QualityCheck feature automatically evaluates the quality of extracted images during fetal diagnosis, supporting consistency of diagnostic accuracy.

 

Jihyun Kim, Head of the CX group at Samsung Medison said: “The Upgraded HERA 20 is more than just an equipment enhancement but it’s a total solution designed to support women’s health across all life stages. By combining AI technology with the healthcare professional’s clinical experience, we aim to enhance diagnostic accuracy and reduce burdens, ultimately driving meaningful change in the healthcare field.”

 

Z20: A Revolutionary Leap in AI-Powered Ob-Gyn Ultrasound at SMFM 2025

 

The Samsung Z20 is set to transform Women’s Health Ultrasound by combining cutting-edge AI tools, unmatched image clarity, and a design built for clinician well-being.

 

Danvers, MA – Jan 29, 2025– Samsung Medison, a global medical equipment company and affiliate of Samsung Electronics, has launched the all-new Samsung Z20 in the U.S.—a premium AI-powered ultrasound system designed for Advanced Ob-Gyn applications. The Z20 made its U.S debut at the Society for Maternal-Fetal Medicine (SMFM) 2025 in Denver, Colorado. The Z20 introduces innovations aimed at overcoming various diagnostic challenges such as high-BMI patients, and operator variability, compounded by staffing shortages which impact exam quality and efficiency.

 

"The Z20 showcases Samsung’s mission to transform women’s health imaging with breakthrough technology that addresses today’s toughest clinical challenges and delivers the quality care every patient deserves" said Kyu Tae Yoo, CEO of Samsung Medison. "We are thrilled to introduce the Z20 to the USA market, reflecting our substantial investment in artificial intelligence and our commitment to maintaining a rapid pace of innovation.”

 

Revolutionizing Workflow with AI

In a healthcare environment increasingly strained by staffing shortages, the Z20’s advanced AI suite streamlines workflows, enabling clinicians of all experience levels to deliver precise, consistent results with ease.

 

A key addition is Live ViewAssist^TM, a real-time deep learning tool that enhances precision and simplifies advanced OB exams. Key capabilities include:

• Streamlines advanced OB exams with automatic identification of 39 views, real-time quality evaluation, and extraction with no user interaction.
• Automatically labels up to 47 anatomic structures and performs 46 essential measurements.
• Reduces keystrokes by up to 94%¹, minimizing repetitive tasks.

 

Improving Diagnostic Accuracy and Patient Outcomes

The Z20’s groundbreaking imaging performance improves diagnostic accuracy, even in challenging cases such as high-BMI patient. Powered by Samsung’s Next-Generation Crystal Architecture ^TM the new imaging engine eliminates technical barriers by incorporating advanced software beamforming.

 

Ergonomic Design for Healthy Scanning

With an alarming 90% of sonographers experiencing work-related musculoskeletal disorders², the Z20 was purpose-built to support healthy scanning practices. Independent testing performed by Sound Ergonomics reports “The Samsung Z20 meets or exceeds 100% of all ergonomic standards measured, making it an ideal choice for healthcare facilities focused on improving sonographer well-being and optimizing workflows.”

 

“The Z20 represents a significant technology milestone for both Samsung and the broader ultrasound industry,” said Tracy Bury, Vice President and Head of Ultrasound USA and of Global Growth Initiatives at Samsung Medison. The Z20 not only highlights Samsung’s remarkable journey from a fast follower to a technology leader, but also reflects our commitment to breaking the iron triangle of healthcare cost, access, and quality by integrating the Z20 with a digital ecosystem for telesonography, reporting, and fleet management.”

 

Samsung and Sonio Unite at SMFM

In 2024, Samsung Medison and Sonio partnered to revolutionize maternal and fetal medicine with innovative AI integration. At SMFM, Sonio will join Samsung to showcase its secure, cloud-based ultrasound reporting and image management solution, powered by FDA-cleared clinical AI. Sonio is also launching Sonio Voice, further demonstrating their commitment to advancing maternal and fetal care with cutting-edge technology.

 

Reference From: https://usa.samsunghealthcare.com/

 

Unlock exclusive market insights. Blog news—Download the Brochure now and dive deeper into the future of the Market

 

Top Companies Related to Railway Modernization and Railway EPC Infrastructure

 

1. GE HealthCare

Founded: 1892

CEO: Peter Arduini

Last Year Revenue: Above USD 19 Billion

GE HealthCare is one of the leading medical technology companies driving the growth of the global diagnostic imaging market through advanced AI-powered imaging systems, precision diagnostics, and intelligent healthcare platforms. The company plays a major role in modern medical imaging through MRI systems, CT scanners, ultrasound platforms, molecular imaging, and AI-enabled radiology workflow solutions. GE HealthCare continues expanding its imaging portfolio through cloud-based imaging software, deep learning reconstruction technologies, and precision care innovations for oncology, cardiology, and women’s health applications. The company has also increased investments in digital imaging ecosystems, portable diagnostics, and AI-assisted automation to improve hospital efficiency and diagnostic accuracy worldwide. Its strong global presence and continuous innovation position the company among the leading diagnostic imaging technology providers globally.

 

2. Siemens Healthineers

Founded: 1847

CEO: Bernd Montag

Last Year Revenue: Above USD 24 Billion

Siemens Healthineers is one of the major companies advancing the global diagnostic imaging market through intelligent imaging systems, AI-driven radiology platforms, and precision healthcare technologies. The company plays a critical role in diagnostic imaging through advanced MRI, CT, PET/CT, angiography, and ultrasound solutions designed for faster and more accurate clinical decision-making. Siemens Healthineers continues strengthening its market position through investments in digital healthcare infrastructure, AI-powered image reconstruction, and automated workflow technologies for hospitals and diagnostic centers. The company recently expanded its smart imaging capabilities with advanced photon-counting CT systems and AI-supported imaging software for oncology and cardiovascular diagnostics. Its continuous focus on innovation, automation, and precision medicine positions the company among the global leaders in next-generation medical imaging technologies.

 

3. Philips

Founded: 1891

CEO: Roy Jakobs

Last Year Revenue: Above USD 19 Billion

Philips is one of the leading healthcare technology companies accelerating growth in the global diagnostic imaging market through connected care solutions, AI-enabled imaging systems, and integrated radiology platforms. The company supports modern healthcare infrastructure through MRI systems, CT scanners, image-guided therapy solutions, ultrasound systems, and cloud-based diagnostic software. Philips continues investing in AI-assisted workflow automation, predictive analytics, and remote diagnostic capabilities to improve clinical efficiency and patient outcomes. The company has also expanded its precision imaging technologies for cardiology, oncology, neurology, and women’s health applications. Through strategic digital healthcare investments and smart imaging innovations, Philips remains one of the most influential companies shaping the future of intelligent diagnostic imaging worldwide.

 

4. Canon Medical Systems

Founded: 1930

CEO: Toshio Takiguchi

Last Year Revenue: Above USD 4 Billion

Canon Medical Systems is one of the prominent companies driving innovation in the global diagnostic imaging market through advanced imaging technologies, AI-assisted diagnostics, and precision healthcare solutions. The company offers a wide range of imaging systems including CT scanners, MRI platforms, ultrasound systems, X-ray devices, and molecular imaging technologies for hospitals and diagnostic centers. Canon Medical continues expanding its AI imaging capabilities through intelligent automation, low-dose imaging solutions, and advanced visualization software designed to improve diagnostic confidence and patient safety. The company is also investing in cardiovascular imaging, oncology diagnostics, and digital healthcare integration to strengthen its global market position. Its focus on innovation, image clarity, and workflow optimization positions the company among the leading global diagnostic imaging providers.

 

5. Samsung Medison

Founded: 1985

CEO: Kyu Tae Yoo

Last Year Revenue: Above USD 500 Million

Samsung Medison is one of the emerging leaders advancing the global diagnostic imaging market through AI-powered ultrasound systems, women’s health imaging technologies, and smart diagnostic solutions. The company plays a major role in ultrasound innovation through obstetrics, gynecology, radiology, and cardiovascular imaging platforms integrated with AI-assisted automation and real-time imaging analysis. Samsung Medison recently showcased advanced ultrasound technologies including the HERA Z20 system and AI-powered PelvicAssist and Live ViewAssist solutions at ISUOG 2025 to improve fetal imaging and gynecological diagnostics. The company continues investing in AI-driven workflow automation, tele-ultrasound collaboration, and patient-centric imaging technologies to strengthen its global healthcare presence. Its rapid innovation in women’s health and ultrasound imaging positions the company among the fast-growing players in the diagnostic imaging industry.

 

6. Fujifilm Healthcare

Founded: 1934

CEO: Teiichi Goto

Last Year Revenue: Above USD 20 Billion

Fujifilm Healthcare is one of the leading healthcare imaging companies driving growth in the global diagnostic imaging market through advanced digital radiology, AI-assisted imaging systems, and healthcare IT solutions. The company offers diagnostic imaging technologies including MRI systems, CT scanners, ultrasound devices, endoscopy systems, and digital X-ray platforms for hospitals and clinics worldwide. Fujifilm continues expanding its AI capabilities through advanced image processing software, cloud imaging platforms, and automated radiology workflow systems designed to improve diagnostic speed and accuracy. The company is also strengthening investments in preventive healthcare imaging, oncology diagnostics, and enterprise imaging integration. Its strong focus on digital transformation and smart healthcare technologies positions the company among the major global diagnostic imaging innovators.

 

7. Hitachi Healthcare

Founded: 1910

CEO: Toshiaki Higashihara

Last Year Revenue: Above USD 70 Billion

Hitachi Healthcare is one of the established companies supporting the growth of the global diagnostic imaging market through advanced imaging systems, healthcare infrastructure technologies, and AI-integrated diagnostics. The company provides MRI systems, ultrasound platforms, CT technologies, and image-guided therapy solutions designed to improve clinical productivity and patient care. Hitachi Healthcare continues focusing on open MRI innovation, patient-friendly imaging systems, and AI-enhanced diagnostic software to improve imaging accessibility and efficiency. The company has also increased investments in digital healthcare integration, precision medicine, and next-generation radiology technologies. Its expertise in engineering and healthcare innovation positions the company among the important contributors to the evolving global diagnostic imaging industry.

 

8. Mindray

Founded: 1991

Chairman: Li Xiting

Last Year Revenue: Above USD 5 Billion

Mindray is one of the rapidly growing medical technology companies driving expansion in the global diagnostic imaging market through affordable imaging systems, smart ultrasound technologies, and AI-enabled healthcare equipment. The company offers advanced ultrasound systems, patient monitoring solutions, in-vitro diagnostics, and radiology imaging technologies for hospitals and healthcare providers globally. Mindray continues strengthening its diagnostic imaging portfolio through AI-assisted imaging tools, portable ultrasound systems, and intelligent workflow automation designed to improve healthcare accessibility and clinical efficiency. The company recently expanded its women’s health imaging and cardiovascular ultrasound capabilities through next-generation AI imaging platforms. Its aggressive international expansion and focus on affordable innovation position the company among the fastest-growing diagnostic imaging providers worldwide.

 

9. Hologic

Founded: 1985

CEO: Stephen P. MacMillan

Last Year Revenue: Above USD 4 Billion

Hologic is one of the leading companies advancing the global diagnostic imaging market through specialized women’s health imaging systems, breast cancer diagnostics, and AI-powered screening technologies. The company plays a major role in modern diagnostic imaging through mammography systems, breast imaging technologies, gynecological diagnostics, and surgical imaging platforms. Hologic continues investing in 3D mammography, AI-assisted breast cancer detection, and precision diagnostic technologies to improve early disease identification and patient outcomes. The company has also expanded its focus on minimally invasive diagnostics and digital imaging integration for women’s healthcare applications. Its leadership in women’s imaging and breast health technologies positions the company among the major innovators in the diagnostic imaging sector.

 

10. Carestream Health

Founded: 2007

CEO: David C. Westgate

Last Year Revenue: Above USD 1 Billion

Carestream Health is one of the important companies contributing to the global diagnostic imaging market through digital radiography systems, medical imaging software, and healthcare IT solutions. The company supports hospitals and diagnostic centers through advanced digital X-ray systems, enterprise imaging platforms, cloud-based radiology solutions, and AI-enhanced workflow technologies. Carestream continues investing in portable imaging systems, remote diagnostics, and intelligent imaging software to improve operational efficiency and healthcare accessibility. The company is also expanding its imaging informatics and digital healthcare capabilities to support connected healthcare infrastructure worldwide. Its strong focus on digital transformation and scalable imaging solutions positions the company among the key players in the evolving diagnostic imaging industry.

 

Unlock exclusive market insights. Blog news—Download the Brochure now and dive deeper into the future of the Market

 

Conclusion: Expert View by Spherical Insights

The global diagnostic imaging market is undergoing a major transformation driven by artificial intelligence, smart automation, precision diagnostics, and rising demand for early disease detection and women’s healthcare imaging. Companies such as Samsung Medison, GE HealthCare, Siemens Healthineers, and Philips are aggressively investing in AI-powered ultrasound systems, intelligent imaging platforms, cloud-connected diagnostics, and workflow automation technologies to improve clinical efficiency and patient outcomes. The launch of Samsung Medison’s HERA Z20 at ISUOG 2025 highlights how the industry is increasingly focusing on women’s health, high-risk pregnancy monitoring, and patient-centric diagnostic solutions. Rising healthcare investments, government support for prenatal screening and diagnostic infrastructure, and increasing adoption of advanced imaging technologies are expected to accelerate market growth through 2035. As hospitals and healthcare providers continue modernizing diagnostic capabilities, the integration of AI, real-time imaging analytics, telehealth imaging, and precision diagnostics will redefine the future of global healthcare and position diagnostic imaging as one of the most strategically important sectors within the broader MedTech industry.